Uncovering the Future of Generic Oncology Drugs: Europe and MENA to See a Surge in Revenue by 2033, Fueled by Increasing Cancer Rates – Insights from Future Market Insights
Rising Prevalence of Cancer to Drive Total Generic Oncology Drug Revenue in Europe and MENA to US$ 8.2 Billion by 2033 Introduction The generic oncology drug market in Europe and the Middle East and North Africa (MENA) region is expected to achieve a compound annual growth rate (CAGR) of 2.1% towards US$ 8.2 billion by…